INSPIREMD INC

InspireMD’s stock slumps 35% from last month’s peak, trading at $0.45 with a $20.9 m market cap, signaling a risky health‑tech investment needing a turnaround.

Explore why Inspiremd (NSPR) is still a high‑risk, speculative stock—low liquidity, steep declines, and unanswered regulatory questions cloud its AMI device prospects.

InspireMD’s share price jumps 2.27% to $0.45 amid healthcare‑tech volatility—learn why the interventional cardiology leader’s AMI focus could spark future growth.

Inspiremd (NSPR) holds flat at $0.44 amid market volatility, but its AMI therapy could drive future growth if regulatory milestones succeed.